• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

How would you bill for intranasal med administration with 2 hours of observation?

acerway

New
Messages
9
Hi all - any ideas on how you would bill for this? I just started working for a psych clinic that is using Spravato (esketamine) treatments for depression. The medicine comes in a pre-measured dose. 2 or 3 doses are self-administered intra-nasally at each treatment. It is required for our staff to make sure the patient self-administers correctly, take repeated vital sign readings, and to directly observe the patient for any adverse reactions for a full and constant 2 hours after the first dose is administered. Patients are treated twice a week for the first 4 weeks. Our physician will create the plan of care, but it is sometimes an LPN or MA that will supervise those 2 hours on the subsequent visits. How would you bill if, on some of these treatments, there was no History or Exam documented for an E/M 9921x code to be used, or if the MA was the only one observing? I can't find anything definitive for that type of encounter. That treatment takes up a lot of clinical resources - any suggestions you have are very much appreciated!
 
Just a heads up that Medicare will cover administration of Spravato with its own G codes next year.
 
Top